Shenzhen Salubris Pharmaceuticals A is a leading Chinese biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines. Its primary focus lies in cardiovascular diseases, oncology, and diabetes to improve global healthcare outcomes and patient wellbeing.
Date confirmed from the official Chinese exchange disclosure timetable.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shenzhen Salubris Pharmaceuticals A is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Shenzhen Salubris Pharmaceuticals A last reported quarterly earnings on 8/25/2026 (Q2 2026).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.